Pharmaceutical Chemistry

Whether you need to ensure quality, source new raw materials or ensure the purity and stability of your existing ones, determine residual solvents in your products or confirm the stability of them, we are here to help.

We can also work with you to develop new test methods.

At Lucideon, we provide more than just numbers - we offer solutions to help you develop new products, optimize existing ones and solve failures quickly.

We are fully GMP certified for quality control testing of human and veterinary medicinal products (full documentation is available to download on the right of this page). All Lucideon’s services are undertaken in compliance with EU guidance on GMP as it applies to contract QC testing laboratories.

We are MHRA-inspected (successfully re-accredited in September 2016), and a UKAS accredited testing house (No. 0013), so you can trust that the test data that we provide to you is accurate and reliable.  Our highly qualified and experienced technical staff use transparent, traceable, calibrated techniques and state-of-the-art equipment.

We have registered (self-identified) with the FDA (U.S. Food and Drugs Administration).  Please see our certificate here

Extractables and Leachables

Extractables and Leachables (E&L) testing is used to identify such compounds and elements by following ISO 10993 and employing a range of analytical techniques. Our expert analysts here at Lucideon can work with you to perform E&L testing and subsequently help to minimise associated risks with your products.

QC (batch release) and Raw Materials Testing

Using a wide range of chemical analysis techniques, we provide QC testing of raw materials, APIs, finished products, packaging materials and medical devices as outlined in marketing authorizations and pharmacopoeias.

Raw Materials Testing

At Lucideon our experts can identify, assay and determine the quality, purity and stability of your raw materials to be used in manufacture. Analysis can be carried out in accordance with pharmacopoeial monographs (Ph. Eur., BP, USP and JP) and/or to your specifications.

Residual Solvent Testing (Organic Volatile Impurities – OVI)

We analyse residual solvents in drug substances, excipients and products as detailed in the USP-NF Chapter <467>. We can develop and validate methods tailored to your specification if required. Residual solvent testing on pharmaceutical products is required to ensure minimal risk levels, such that they do not impact on patient safety.

Method Development and Validation

Our experienced scientists can develop new methods for your products.  These can be developed and validated to ICH guidelines which include the following parameters:

  • Linearity
  • Limit of detection (LOD)
  • Limit of quantification (LOQ)
  • Specificity (including stability of solutions)
  • Precision (method, intermediate and system)
  • Accuracy (recoveries)
  • Robustness
  • Forced degradation.

Stability Storage and Testing

Our storage stability walk-in chambers, controlled to ICH guidelines, are monitored 24/7/365 and have built-in safeguards to give you peace of mind. Additional stand-alone cabinets enable us to offer alternative parameters including refrigerated, frozen and client defined storage conditions.

The standard ICH conditions are:

  • 25°C/60%RH - Real time storage condition
  • 30°C/65%RH - Intermediate storage condition
  • 40°C/75%RH - Accelerated storage condition.

Our experienced staff can aid with study design, planning and management of stability storage testing.

Water Analysis

Whether its analysing water quality to pharmacopoeial monographs (Ph. Eur., USP, BP, JP), HTM directives, Microbiology of Drinking Water or Total Organic Carbon (TOC) - at Lucideon we can help.

Cleaning and Sterilization Validation of Reusable Medical Devices

Medical devices need to be cleaned thoroughly and effectively to ensure their safety in use. Reusable devices (such as surgical tools etc.) require reprocessing (cleaning and disinfection/sterilization) between each use. To ensure the effectiveness of such reprocessing methods, manufacturers are required to validate their cleaning and disinfection/sterilization processes as part of the device instructions for use (IFU).

Got a question?

Contact us here

Resources

  • White paper

    Are you Ready for USP <232>/<233>?

    pdf 249 KB

  • White paper

    Quality by Design for the Pharmaceutical Industry

    pdf 835 KB

  • White paper

    Abuse Deterrence for the Pharmaceutical Market

    pdf 2 MB

  • White paper

    Surface Analysis Exposes Counterfeit Medicines

    pdf 479 KB

  • Newsletter

    Pharmaceutical Newsletter

    pdf 418 KB

Register or sign in below to access our resources.

Register

Forgot your password?